These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 32495058)

  • 1. Statin Intolerance in Clinical Practice.
    Snejdrlova M; Altschmiedova T; Vrablik M; Stulc T; Lastuvka J; Lanska V; Ceska R
    Curr Atheroscler Rep; 2020 Jun; 22(7):27. PubMed ID: 32495058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness and tolerability of every-other-day rosuvastatin dosing in patients with prior statin intolerance.
    Backes JM; Venero CV; Gibson CA; Ruisinger JF; Howard PA; Thompson PD; Moriarty PM
    Ann Pharmacother; 2008 Mar; 42(3):341-6. PubMed ID: 18285559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A common missense variant of LILRB5 is associated with statin intolerance and myalgia.
    K Siddiqui M; Maroteau C; Veluchamy A; Tornio A; Tavendale R; Carr F; Abelega NU; Carr D; Bloch K; Hallberg P; Yue QY; Pearson ER; Colhoun HM; Morris AD; Dow E; George J; Pirmohamed M; Ridker PM; Doney ASF; Alfirevic A; Wadelius M; Maitland-van der Zee AH; Chasman DI; Palmer CNA;
    Eur Heart J; 2017 Dec; 38(48):3569-3575. PubMed ID: 29020356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PRavastatin Versus FlUVastatin After Statin Intolerance: The PRUV-Intolerance Study With Propensity Score Matching.
    Roh JW; Chun KH; Kang M; Lee CJ; Oh J; Shim CY; Ahn CM; Kim JS; Kim BK; Park S; Chang HJ; Hong GR; Ko YG; Kang SM; Choi D; Ha JW; Hong MK; Jang Y; Lee SH
    Am J Med; 2019 Nov; 132(11):1320-1326.e1. PubMed ID: 31278931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Practical approach to statin intolerance].
    Štulc T; Beránková Š; Češka R
    Vnitr Lek; 2015 Nov; 61(11):936-41. PubMed ID: 26652780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of patients with statin intolerance.
    Fischer S; Julius U
    Atheroscler Suppl; 2017 Nov; 30():33-37. PubMed ID: 29096858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative effectiveness of statins in secondary prevention among the older people aged 75 years and over.
    Kwak A; Kim JH; Choi CU; Kim IW; Oh JM; Kim K
    Int J Clin Pharm; 2019 Apr; 41(2):460-469. PubMed ID: 30864086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Finding the Balance Between Benefits and Harms When Using Statins for Primary Prevention of Cardiovascular Disease: A Modeling Study.
    Yebyo HG; Aschmann HE; Puhan MA
    Ann Intern Med; 2019 Jan; 170(1):1-10. PubMed ID: 30508425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Statin Intolerance: the Clinician's Perspective.
    Stulc T; Ceška R; Gotto AM
    Curr Atheroscler Rep; 2015 Dec; 17(12):69. PubMed ID: 26490078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Statin intolerance - an attempt at a unified definition. Position paper from an International Lipid Expert Panel.
    Banach M; Rizzo M; Toth PP; Farnier M; Davidson MH; Al-Rasadi K; Aronow WS; Athyros V; Djuric DM; Ezhov MV; Greenfield RS; Hovingh GK; Kostner K; Serban C; Lighezan D; Fras Z; Moriarty PM; Muntner P; Goudev A; Ceska R; Nicholls SJ; Broncel M; Nikolic D; Pella D; Puri R; Rysz J; Wong ND; Bajnok L; Jones SR; Ray KK; Mikhailidis DP
    Expert Opin Drug Saf; 2015 Jun; 14(6):935-55. PubMed ID: 25907232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Statin Use and Adverse Effects Among Adults >75 Years of Age: Insights From the Patient and Provider Assessment of Lipid Management (PALM) Registry.
    Nanna MG; Navar AM; Wang TY; Mi X; Virani SS; Louie MJ; Lee LV; Goldberg AC; Roger VL; Robinson J; Peterson ED
    J Am Heart Assoc; 2018 May; 7(10):. PubMed ID: 29739801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NLA scientific statement on statin intolerance: a new definition and key considerations for ASCVD risk reduction in the statin intolerant patient.
    Cheeley MK; Saseen JJ; Agarwala A; Ravilla S; Ciffone N; Jacobson TA; Dixon DL; Maki KC
    J Clin Lipidol; 2022; 16(4):361-375. PubMed ID: 35718660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Statin-associated incident diabetes: a literature review.
    Park ZH; Juska A; Dyakov D; Patel RV
    Consult Pharm; 2014; 29(5):317-34. PubMed ID: 24849689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypothyroidism as a risk factor for statin intolerance.
    Robison CD; Bair TL; Horne BD; McCubrey RO; Lappe DL; Muhlestein JB; Anderson JL
    J Clin Lipidol; 2014; 8(4):401-7. PubMed ID: 25110221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and laboratory phenotype of patients experiencing statin intolerance attributable to myalgia.
    Harris LJ; Thapa R; Brown M; Pabbathi S; Childress RD; Heimberg M; Braden R; Elam MB
    J Clin Lipidol; 2011; 5(4):299-307. PubMed ID: 21784376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Daily and intermittent rosuvastatin 5 mg therapy in statin intolerant patients: an observational study.
    Meek C; Wierzbicki AS; Jewkes C; Twomey PJ; Crook MA; Jones A; Viljoen A
    Curr Med Res Opin; 2012 Mar; 28(3):371-8. PubMed ID: 22256801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current treatment of dyslipidaemia: PCSK9 inhibitors and statin intolerance.
    Koskinas K; Wilhelm M; Windecker S
    Swiss Med Wkly; 2016; 146():w14333. PubMed ID: 27400448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cholesterol level goal attainment with statins: clinical management guideline recommendations versus management in actual clinical practice.
    Heintjes EM; Penning-van Beest FJ; Plat AW; Meerding WJ; Webb K; Sturkenboom MC; Herings RM
    Pharmacotherapy; 2012 Jul; 32(7):631-41. PubMed ID: 22760692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Statin-associated muscle symptoms and SLCO1B1 rs4149056 genotype in patients with familial hypercholesterolemia.
    Khine H; Yuet WC; Adams-Huet B; Ahmad Z
    Am Heart J; 2016 Sep; 179():1-9. PubMed ID: 27595674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Justification for the Use of Statins in Primary Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER)--can C-reactive protein be used to target statin therapy in primary prevention?
    Mora S; Ridker PM
    Am J Cardiol; 2006 Jan; 97(2A):33A-41A. PubMed ID: 16442935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.